Screener
X4 Pharmaceuticals XFOR Q2 2025 earnings
Reported August 8, 2025 · Before market open
Revenue$2.0MMiss by $253.4K
EPS-$3.47Beat by $1.06
Revenue estimate$2.2M
EPS estimate-$4.53
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$2.3M
EPS estimate-$0.19
Versus estimates
Revenue
Diluted EPS
FAQ
- When did X4 Pharmaceuticals report Q2 2025 earnings?
- X4 Pharmaceuticals (XFOR) reported Q2 2025 earnings on August 8, 2025 before market open.
- What were X4 Pharmaceuticals's Q2 2025 revenue and EPS?
- X4 Pharmaceuticals reported revenue of $2.0M and eps of $-3.47 for Q2 2025.
- Did X4 Pharmaceuticals beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $2.2M by $253.4K. EPS beat the consensus estimate of $-4.53 by $1.06.
- How did X4 Pharmaceuticals's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 250.4% from $563.0K a year earlier and eps declined 4857.1% from $-0.07.
- Where can I find X4 Pharmaceuticals's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001628280-25-039327) directly on SEC EDGAR. The filing index links above go to sec.gov.
